Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Accounting Policies, by Policy (Policies)
Notes Tables
Notes Details

SHARE-BASED COMPENSATION (Tables)

v3.22.1

SHARE-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2022

Share-Based Compensation [Abstract]

Schedule of share-based compensation plans

Common shares outstanding, March 31, 2022	111,202,690
Share-based compensation available for issuance: 15%		16,680,404
Stock options outstanding, March 31, 2022		(4,830,628	)
RSU outstanding, March 31, 2022		(1,730,605	)
Share-based compensation available for future grants		10,119,171

Schedule of granted stock options to acquire common stock

	2022					2021
	Stock Options			Weighted Average Exercise Price		Stock Options			Weighted Average Exercise Price
Balance, January 1	$	5,257,089		$	1.73	$	2,923,770		$	1.76
Granted		-			-		1,801,262			2.21
Forfeited		(426,461	)		2.38		(10,663	)		2.76
Expired		-			-		(9,810	)		3.61
Exercised		-			-		(19,568	)		0.73
Balance, March 31	$	4,830,628		$	1.73	$	4,685,021		$	1.93

Schedule of granted restricted share units

	2022	2021
Balance at Jan 1	1,581,607		-
Granted	148,998		1,527,860
Released	-		-
Cancelled	-		-
Balance, March 31	1,730,605		1,527,860

Schedule of stock-based compensation expense

	Three Months Ended
	March 31, 2022		March 31, 2021
	$		$
Stock options		212		316
RSUs		209		342
G&A - Stock options & RSUs		421		658
R&D - Stock options		172		111
Share-based compensation expense		593		769

- Definition

The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Disclosure of detailed information about stock-based compensation expense.

+ References

No definition available.

+ Details

Name:	tmdi_DisclosureOfDetailedInformationAboutStockBasedCompensationExpenseExplanatory
Namespace Prefix:	tmdi_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	tmdi_DisclosureOfShareBasedPaymentArrangementsTextBlockAbstract
Namespace Prefix:	tmdi_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration